Type :
Lobbyiste-conseil
Lobbyiste :
Howard Brown,
Brown & Cohen Communications & Public Affairs
A eu lieu :
2021-01-14
Publié :
2021-01-15
Titulaires de charge publique désignée :
Marc Lamoureux,
Manager,
Bureau of Evaluation (Digital Health)
| Santé Canada (SC)
Emily Hollink,
A/Director,
Bureau of Investigational Testing Authorization, Special Access Program and Post-Market surveillance (Investigational Testing Division)
| Santé Canada (SC)
Elaine Wong,
Senior Scientific Evaluator,
Bureau of Investigational Testing Authorization, Special Access Program and Post-Market surveillance (Investigational Testing Division)
| Santé Canada (SC)
Justin Peterson,
Scientific Evaluator,
Bureau of Evaluation (Digital Health)
| Santé Canada (SC)
Christine Lefebvre,
A/Manager,
Medical Devices COVID-19 Task Team
| Santé Canada (SC)
Thomas Hazle,
Supervisor,
Bureau of Licensing Services
| Santé Canada (SC)
Eram Rashid,
A/Regulatory Affairs Specialist,
Bureau of Investigational Testing Authorization, Special Access Program and Post-Market surveillance (Investigational Testing Division)
| Santé Canada (SC)
Tyler Dumouchel,
Scientific Evaluator,
Bureau of Evaluation (Digital Health)
| Santé Canada (SC)
Zehra Murtaza,
Senior Regulatory Affairs Officer,
Bureau of Licensing Services
| Santé Canada (SC)
Julie Ballantyne,
Manager,
Policy and Strategic Integration Branch of the COVID-19 Taskforce
| Santé Canada (SC)
